Bioventus Inc. — Director's Dealing 2025

Apr 11, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Bioventus Inc. (BVS)
CIK: 0001665988
Period of Report: 2025-04-10

Reporting Person: Singleton Mark Leonard (SVP & CFO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2025-04-10	Class A Common Stock	M	13000	—	Acquired	144963	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2025-04-10	Restricted Stock Units	$	M	13000	Disposed		Class A Common Stock (13000)	Direct

Footnotes

F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Class A common stock.

F2: The RSUs shall vest in four equal installments on each of the first four anniversaries of April 10, 2023, in each case subject to the Reporting Person continuing in service through the applicable vesting date.